A biotech veteran gives his take on volatile times and allo CAR-T.
- blonca9
- Jan 10, 2023
- 1 min read
Updated: Jun 17, 2023
Arie Belldegrun talks about navigating tough times during biotech downturns and allogeneic CAR-T.
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.